日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML

V-FAST:一项 1b 期主试验,旨在研究 CPX-351 联合靶向药物治疗新诊断 AML 成人患者的疗效。

Pullarkat, Vinod A; Levis, Mark; McCloskey, James; Mannis, Gabriel N; Strickland, Stephen A; Fathi, Amir T; Lin, Tara L; Bhatt, Vijaya R; Vanniyasingam, Thuva; Chakravarthy, Divya; Lutska, Yana; Faderl, Stefan; Cheung, Ronald S; Erba, Harry P

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial

达雷妥尤单抗、来那度胺、硼替佐米和地塞米松联合治疗适合移植的新诊断多发性骨髓瘤:GRIFFIN试验

Voorhees, Peter M; Kaufman, Jonathan L; Laubach, Jacob; Sborov, Douglas W; Reeves, Brandi; Rodriguez, Cesar; Chari, Ajai; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Murphy, Sean; Lutska, Yana; Pei, Huiling; Ukropec, Jon; Vermeulen, Jessica; de Boer, Carla; Hoehn, Daniela; Lin, Thomas S; Richardson, Paul G

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

达雷妥尤单抗、硼替佐米、环磷酰胺和地塞米松治疗新诊断和复发性多发性骨髓瘤:LYRA 研究

Yimer, Habte; Melear, Jason; Faber, Edward; Bensinger, William I; Burke, John M; Narang, Mohit; Stevens, Don; Gunawardena, Sriya; Lutska, Yana; Qi, Keqin; Ukropec, Jon; Qi, Ming; Lin, Thomas S; Rifkin, Robert M